18 results
Thumbnail

D2.100 - Carcinoid Crisis Mimicking IgE-Mediated Hypersensitivity Reaction During Peptide Receptor Radionuclide Therapy (PRRT): A Diagnostic Dilemma

Thumbnail

D2.103 - Severe Persistent Allergic Rhinitis in an Adolescent: A SNOT-22–Based Case Report

Thumbnail

D2.104 - Mental Health Care and Support in Patients with Atopic Dermatitis in Kazakhstan: One-Year Follow-Up Study

Thumbnail

D2.92 - LTP-Mediated Corn-Induced Anaphylaxis

Thumbnail

D2.93 - The role of tropomyosins in allergenic cross-reactivity

Thumbnail

D2.94 - Anaphylaxis to human serum albumin in a patient with liver cirrhosis – a diagnostic challenge

Thumbnail

D2.96 - Perioperative Anaphylaxis in Sri Lanka: Evaluation in a Low-Resource Setting

Thumbnail

D2.97 - Overall Prevalence and Particular Importance of Studying Sensitization to Peanut Molecules

Thumbnail

D2.98 - Allergic Contact Dermatitis from 2-Hydroxyethyl Methacrylate in a Nail Technician

Thumbnail

D2.99 - The mysterious cases of anaphylaxis to döner kebab in Germany/Switzerland with subsequent tolerance in Türkiye: an unwelcome guest causes trouble

Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis

Thumbnail

D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial

Thumbnail

D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to

Thumbnail

D2.503 - LP-003 Injection for the treatment of H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU): A Multicenter, Randomized, Double-Blind, Controlled Phase Ⅱ Study